Data without a clear conclusion
The data exist, but the analysis or biological interpretation is stalled.
Biological & biotechnology R&D × data science
Bring me in when an analysis is stalled, an experiment needs an independent review, or complex results must become a clear manuscript, figure set, or R&D decision. I combine experimental biology, genomics, statistics, reproducible R/Python, and fit-for-purpose machine learning.
Between the datasets
Most R&D teams have more data than time. Analyses get postponed, designs get locked in under deadline, and experiments can end up addressing something slightly different from what originally mattered.
The evidence behind an important decision rarely lives in one dataset. Sequencing data may sit with one team, phenotyping or imaging with another, and molecular assays, analytical measurements, or process data somewhere else again.
My approach is simple: start with the biological question, make uncertainty visible, and build only the analysis the decision requires.
Across Puregene AG, the Salk Institute, and Yale University, I have worked at the intersection of genome editing, genomics, molecular biology, imaging, statistics, and machine learning—from applied R&D to fundamental questions involving DNA replication and chromatin.
Bridging those gaps is the work.
Public examples use only open, synthetic, or independently created materials. No confidential or proprietary information is included.
When to bring me in
The data exist, but the analysis or biological interpretation is stalled.
The design, controls, endpoints, or analysis plan need an independent review.
A manuscript, report, or figure set needs a clearer evidence-based narrative.
Genomics, phenotyping, imaging, and molecular results do not yet support one decision.
Consulting process
Clarify the scientific question, priorities, and desired outcome.
Agree on deliverables, timing, and boundaries.
Complete the analysis, review, figures, writing, or experimental guidance.
Deliver documented results, reusable files, and clear next steps.
Research & scientific impact
A scientific track record spanning genome editing, plant developmental biology, deep-learning phenotyping, and translational research.
Co-inventor on a published international patent application covering compositions and genome-editing methods designed to increase root periderm and suberin.
Connected experimental design, floral synchronization, an SHP2-specific reporter, FACS, wet-lab biology, RNA-seq, bioinformatics, interpretation, and scientific writing to resolve a reproductive meristem at cell-type resolution.
Hands-on genome-editing expertise across Arabidopsis and crop systems — including cannabis and Solanaceae — connecting CRISPR strategy, molecular validation, phenotyping, genomics, and reproducible analysis.








Selected publications
Peer-reviewed work connecting molecular mechanisms with experimental evidence, high-throughput genomics, genome editing, and quantitative methods.
Browse the complete publication record on Google Scholar ↗RNA-seq · FACS · reproductive meristems · Arabidopsis
View publication ↗ScienceChromatin biology · DNA replication · genome stability
View publication ↗The Plant CellEpigenetics · chromatin · transcriptional silencing · genome stability
View publication ↗Nature PlantsComparative genomics · Solanaceae evolution · crop biology
View publication ↗DevelopmentCRISPR/Cas9 · reproductive development · Arabidopsis
View publication ↗Plant PhenomicsDeep learning · phenotyping · automated microscopy
View publication ↗Selected work
Independent examples demonstrating how I approach uncertainty, validation, reproducible analysis, and scientific communication.
Machine learning · synthetic data
Problem
Biological classifiers can look accurate while failing on new experimental groups.
Approach
Built a confidentiality-safe workflow with group-aware validation, calibration, model comparison, and interpretable features.
Result
A reproducible demonstration that exposes leakage and quantifies predictive uncertainty.
Decision
Whether a model is reliable enough to guide further biological validation.
Healthcare operations · data analysis
Problem
Delays between discharge orders and departures are important but easy to describe without testing.
Approach
Defined measurable intervals, compared groups statistically, and built decision-focused visualisations.
Result
A reproducible, patient-data-free case study separating patterns from unsupported assumptions.
Decision
Where operational review or targeted data collection should begin.
First-author research · Plant Physiology
Problem
The identity of a small reproductive domain was obscured by mixed tissue and processing effects.
Approach
Combined floral synchronization, an SHP2-specific reporter, FACS, RNA-seq, and stringent filtering.
Result
Identified 363 differentially expressed genes and evidence of a meristematic identity.
Decision
Which candidate regulators warranted functional follow-up.
ML phenotyping · GWAS-ready
Problem
Manual periderm measurements limited experimental scale and reproducibility.
Approach
Combined staining, automated microscopy, and UNet++ segmentation across 20 natural accessions.
Result
Automated measurements reached 94% efficiency relative to expert measurements.
Decision
Enabled scalable traits for genome-wide association mapping and mutant screening.
How I can help
Review the design, sampling, controls, endpoints, and analysis plan before valuable samples or resources are committed.
Explore serviceClose details+Turn an existing biological dataset into a documented analysis, reproducible code, clear figures, and conclusions your team can use.
Explore serviceClose details+Build fit-for-purpose analytical and predictive workflows for genomics, imaging, phenotyping, sensory, and other biological data.
Explore serviceClose details+Independent scientific feedback for refining, troubleshooting, and interpreting molecular-biology experiments and workflows.
Explore serviceClose details+Research background
My perspective comes from working across discovery science, genomics, bioengineering, and commercial R&D. I understand the experimental context behind the dataset — and the decisions waiting on the other side.
2025 — 2026
Senior Scientist / Data Scientist
Cannabis genome-editing platform · applied crop R&D · quantitative analysis · genomics
2019 — 2024
Research Scientist
Plant genomics · RNA-seq · GWAS · machine learning · gene editing · patent application
Research group · Busch Lab
2016 — 2018
Postdoctoral Researcher
Genome stability · epigenetics · histone modification · CRISPR/Cas9 · DNA replication
Research group · Jacob Lab
2014 — 2016
NSF Postdoctoral Fellow
Cell-type transcriptomics · FACS · developmental biology
Research group · Franks Lab
2008 — 2014
Ph.D., Plant Sciences
Molecular biology · genomics/transcriptomics
Research group · Mattson Lab
Project enquiries
Send a short description of the question, dataset, or project stage. I'll reply with whether I can help and what a focused first step could look like.